Universitat de Barcelona-ko ikertzaileekin lankidetzan egindako argitalpenak (1)

2017

  1. Silencing of foxp3 enhances the antitumor efficacy of GM-CSf genetically modified tumor cell vaccine against B16 melanoma

    OncoTargets and Therapy, Vol. 10, pp. 503-514